PMID- 18606850 OWN - NLM STAT- MEDLINE DCOM- 20080808 LR - 20211020 IS - 1540-8140 (Electronic) IS - 0021-9525 (Print) IS - 0021-9525 (Linking) VI - 182 IP - 1 DP - 2008 Jul 14 TI - TWEAK-FN14 signaling induces lysosomal degradation of a cIAP1-TRAF2 complex to sensitize tumor cells to TNFalpha. PG - 171-84 LID - 10.1083/jcb.200801010 [doi] AB - Synthetic inhibitor of apoptosis (IAP) antagonists induce degradation of IAP proteins such as cellular IAP1 (cIAP1), activate nuclear factor kappaB (NF-kappaB) signaling, and sensitize cells to tumor necrosis factor alpha (TNFalpha). The physiological relevance of these discoveries to cIAP1 function remains undetermined. We show that upon ligand binding, the TNF superfamily receptor FN14 recruits a cIAP1-Tnf receptor-associated factor 2 (TRAF2) complex. Unlike IAP antagonists that cause rapid proteasomal degradation of cIAP1, signaling by FN14 promotes the lysosomal degradation of cIAP1-TRAF2 in a cIAP1-dependent manner. TNF-like weak inducer of apoptosis (TWEAK)/FN14 signaling nevertheless promotes the same noncanonical NF-kappaB signaling elicited by IAP antagonists and, in sensitive cells, the same autocrine TNFalpha-induced death occurs. TWEAK-induced loss of the cIAP1-TRAF2 complex sensitizes immortalized and minimally passaged tumor cells to TNFalpha-induced death, whereas primary cells remain resistant. Conversely, cIAP1-TRAF2 complex overexpression limits FN14 signaling and protects tumor cells from TWEAK-induced TNFalpha sensitization. Lysosomal degradation of cIAP1-TRAF2 by TWEAK/FN14 therefore critically alters the balance of life/death signals emanating from TNF-R1 in immortalized cells. FAU - Vince, James E AU - Vince JE AD - Department of Biochemistry, La Trobe University, Kingsbury Drive, Melbourne, VIC 3086, Australia. FAU - Chau, Diep AU - Chau D FAU - Callus, Bernard AU - Callus B FAU - Wong, W Wei-Lynn AU - Wong WW FAU - Hawkins, Christine J AU - Hawkins CJ FAU - Schneider, Pascal AU - Schneider P FAU - McKinlay, Mark AU - McKinlay M FAU - Benetatos, Christopher A AU - Benetatos CA FAU - Condon, Stephen M AU - Condon SM FAU - Chunduru, Srinivas K AU - Chunduru SK FAU - Yeoh, George AU - Yeoh G FAU - Brink, Robert AU - Brink R FAU - Vaux, David L AU - Vaux DL FAU - Silke, John AU - Silke J LA - eng PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20080707 PL - United States TA - J Cell Biol JT - The Journal of cell biology JID - 0375356 RN - 0 (Caspase Inhibitors) RN - 0 (Inhibitor of Apoptosis Proteins) RN - 0 (NF-kappa B) RN - 0 (Receptors, Tumor Necrosis Factor) RN - 0 (TNF Receptor-Associated Factor 2) RN - 0 (TNFRSF12A protein, human) RN - 0 (TWEAK Receptor) RN - 0 (Tnfrsf12a protein, mouse) RN - 0 (Tumor Necrosis Factor-alpha) RN - EC 3.4.- (Cathepsins) SB - IM CIN - J Cell Biol. 2008 Jul 14;182(1):15-7. PMID: 18606854 MH - Animals MH - Caspase Inhibitors MH - Cathepsins/metabolism MH - Cell Death/drug effects MH - Cell Line, Transformed MH - Cell Line, Tumor MH - Humans MH - Inhibitor of Apoptosis Proteins/chemistry/*metabolism MH - Lysosomes/drug effects/*metabolism MH - Mice MH - Models, Biological MH - NF-kappa B/metabolism MH - Protein Binding/drug effects MH - Protein Processing, Post-Translational/*drug effects MH - Protein Structure, Tertiary MH - Receptors, Tumor Necrosis Factor/*metabolism MH - Signal Transduction/*drug effects MH - TNF Receptor-Associated Factor 2/*metabolism MH - TWEAK Receptor MH - Tumor Necrosis Factor-alpha/*pharmacology PMC - PMC2447903 EDAT- 2008/07/09 09:00 MHDA- 2008/08/09 09:00 PMCR- 2009/01/14 CRDT- 2008/07/09 09:00 PHST- 2008/07/09 09:00 [pubmed] PHST- 2008/08/09 09:00 [medline] PHST- 2008/07/09 09:00 [entrez] PHST- 2009/01/14 00:00 [pmc-release] AID - jcb.200801010 [pii] AID - 200801010 [pii] AID - 10.1083/jcb.200801010 [doi] PST - ppublish SO - J Cell Biol. 2008 Jul 14;182(1):171-84. doi: 10.1083/jcb.200801010. Epub 2008 Jul 7.